Autophagic-Lysosomal pathway is the main proteolytic system modified in the skeletal muscle of esophageal cancer patients1-3

American Journal of Clinical Nutrition

Volumn 98, Issue 6, 2013, Pages 1485-1492

  Tardif, Nicolas ^a   Klaude, Maria ^a   Lundell, Lars ^b   Thorell, Anders ^c   Rooyackers, Olav ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c ERSTA HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; CASPASE 3; CATHEPSIN B; CATHEPSIN L; COUMARIN DERIVATIVE; MICROTUBULE ASSOCIATED PROTEIN 1; PROTEASOME; PROTEIN P62; UBIQUITIN PROTEIN LIGASE;

ADULT; ANTIREFLUX OPERATION; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CACHEXIA; CANCER PATIENT; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAPHRAGM MUSCLE; ENZYME ACTIVITY; ESOPHAGUS CANCER; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; LAPAROSCOPIC SURGERY; LYSOSOME; MALE; MUSCLE ATROPHY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SKELETAL MUSCLE; VASTUS LATERALIS MUSCLE;

AGED; AUTOPHAGY; BIOLOGICAL MARKERS; CACHEXIA; CATHEPSIN B; CATHEPSIN L; DIAPHRAGM; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LIPID METABOLISM; LYSOSOMES; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MUSCLE, SKELETAL; PROTEOLYSIS; QUADRICEPS MUSCLE; REPRODUCIBILITY OF RESULTS; UP-REGULATION;

EID: 84888234036     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.113.063859     Document Type: Article

References (45)

1. Prado CM, Baracos VE, McCargar LJ, Reiman T, Mourtzakis M, Tonkin K, Mackey JR, Koski S, Pituskin E, Sawyer MB. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 2009;15:2920-6
2. van Vledder MG, Levolger S, Ayez N, Verhoef C, Tran TC, Ijzermans JN. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg 2012;99:550-7
3. Villaseñor A, Ballard-Barbash R, Baumgartner K, Baumgartner R, Bernstein L, McTiernan A, Neuhouser ML. Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL Study. J Cancer Surviv 2012;6:398-406
4. Powers SK, Kavazis AN, DeRuisseau KC. Mechanisms of disuse muscle atrophy: role of oxidative stress. Am J Physiol Regul Integr Comp Physiol 2005;288:R337-44
5. Mitch WE, Goldberg AL. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med 1996;335:1897-905
6. Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J, Price SR, Mitch WE, Goldberg AL. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 2004;18:39-51
7. Pickart CM. Mechanisms underlying ubiquitination. Annu Rev Biochem 2001;70:503-33.
8. Voges D, Zwickl P, Baumeister W. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu Rev Biochem 1999; 68:1015-68
9. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, et al. Identification of ubiquitin ligases required for keletal muscle atrophy. Science 2001; 294:1704-8
10. Stephens NA, Gallagher IJ, Rooyackers O, Skipworth RJ, Tan BH, Marstrand T, Ross JA, Guttridge DC, Lundell L, Fearon KC, et al. Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cancer cachexia. Genome Med. 2010;2:1
11. Bossola M, Muscaritoli M, Costelli P, Grieco G, Bonelli G, Pacelli F, Rossi Fanelli F, Doglietto GB, Baccino FM. Increased muscle proteasome activity correlates with isease severity in gastric cancer patients. Ann Surg 2003;237:384-9
12. Op den Kamp CM, Langen RC, Minnaard R, Kelders MC, Snepvangers FJ, Hesselink MK, Dingemans AC, Schols AM. Pre-cachexia in patients with stages 1-3 non-small cell ung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system. Lung Cancer 2012;76:112-7
13. Jagoe RT, Redfern CP, Roberts RG, Gibson GJ, Goodship TH. Skeletal muscle mRNA levels for cathepsin B, but not components of the ubiquitin-proteasome pathway, are increased in patients with lung cancer referred for thoracotomy. Clin Sci (Lond) 2002;102:353-61.
14. Op den Kamp CM, Langen RC, Snepvangers FJ, de Theije CC, Schellekens JM, Laugs F, Dingemans AM, Schols AM. Nuclear transcription factor kappa B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia. Am J Clin Nutr 2013;98:738-48
15. Sandri M. Autophagy in skeletal muscle. FEBS Lett 2010;584: 1411-6.
16. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature 2008;451:1069-75
17. Bechet D, Tassa A, Taillandier D, Combaret L, Attaix D. Lysosomal proteolysis in skeletal muscle. Int J Biochem Cell Biol 2005;37: 2098-114
18. Scherstén T, Lundholm K. Lysosomal enzyme activity in muscle tissue from patients with malignant tumor. Cancer 1972;30:1246-51
19. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002;50:889-96
20. Kim J, Wang Z, Heymsfield SB, Baumgartner RN, Gallagher D. Totalbody skeletal scle mass: estimation by a new dual-energy X-ray absorptiometry method. Am J Clin Nutr 2002;76:378-83
21. Klaude M, Fredriksson K, Tjader I, Hammarqvist F, Ahlman B,Rooyackers O, Wernerman J. Proteasome proteolytic activity in skeletal muscle is increased in patients with sepsis. Clin Sci (Lond) 2007; 112:499-506
22. Friedrich B, Jung K, Lein M, Turk I, Rudolph B, Hampel G, Schnorr D, Loening SA. Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue. Eur J Cancer 1999;35:138-44
23. Klaude M, Mori M, Tjader I, Gustafsson T, Wernerman J, Rooyackers O. Protein metabolism and gene expression in skeletal muscle of critically ill patients with sepsis. Clin Sci (Lond) 2012;122:133-42
24. Welinder C, Ekblad L. Coomassie staining as loading control in Western blot analysis. J Proteome Res 2011;10:1416-9
25. Gibbs J, Cull W, Henderson W, Daley J, Hur K, Khuri SF. Preoperative serum albumin level as a predictor of operative mortality and orbidity: results from the National VA Surgical Risk Study. Arch Surg 1999;134:36-42
26. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008;132:27-42
27. Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS, Baba M, Baehrecke EH, Bahr BA, Ballabio A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy in highereukaryotes. Autophagy 2008;4:151-75
28. Costelli P, Bossola M, Muscaritoli M, Grieco G, Bonelli G, Bellantone R, Doglietto GB, Baccino FM, Rossi Fanelli F. Anticytokine treatment prevents the increase in the activity of ATP-ubiquitin- And Ca(2+)-dependent proteolytic systems in the muscle of tumour-bearing rats. Cytokine 2002; 19:1-5
29. Baracos VE, DeVivo C, Hoyle DH, Goldberg AL. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. Am J Physiol 1995;268:E996-1006.
30. Temparis S, Asensi M, Taillandier D, Aurousseau E, Larbaud D, Obled A, Bechet D, Ferrara M, Estrela JM, Attaix D. Increased ATP-ubiquitindependent proteolysis in skeletal muscles of tumor-bearing rats. Cancer Res 1994;54:5568-73
31. Lorite MJ, Thompson MG, Drake JL, Carling G, Tisdale MJ. Mechanism of muscle protein degradation induced by a cancer cachectic factor. Br J Cancer 1998;78:850-6
32. Khal J, Hine AV, Fearon KC, Dejong CH, Tisdale MJ. Increased expression of proteasome subunits in skeletal muscle of cancer patients with weight loss. Int J Biochem Cell Biol 2005;37:2196-206
33. Busquets S, Deans C, Figueras M, Moore-Carrasco R, Lopez-Soriano FJ, Fearon KC, Argiles JM. Apoptosis is present in skeletal muscle of cachectic gastro-intestinal cancer patients. Clin Nutr 2007;26:614-8
34. Bossola M, Mirabella M, Ricci E, Costelli P, Pacelli F, Tortorelli AP, Muscaritoli M, Rossi Fanelli F, Baccino FM, Tonali PA, et al. Skeletal muscle apoptosis is not increased in gastric cancer patients with mildmoderateweight loss. Int J Biochem Cell Biol 2006;38:1561-70
35. Costelli P, De Tullio R, Baccino FM, Melloni E. Activation of Ca(2+)-dependent proteolysis in skeletal muscle and heart in cancercachexia. Br J Cancer 2001;84:946-50
36. Malicdan MC, Noguchi S, Nonaka I, Saftig P, Nishino I. Lysosomal myopathies: an excessive build-up in autophagosomes is too much to handle. Neuromuscul Disord 2008;18:521-9
37. Penna F, Costamagna D, Pin F, Camperi A, Fanzani A, Chiarpotto EM, Cavallini G, Bonelli G, Baccino FM, Costelli P. Autophagic degradation contributes to muscle wasting in cancer cachexia. Am J Pathol 2013;182:1367-78
38. Ju JS, Miller SE, Jackson E, Cadwell K, Piwnica-Worms D, Weihl CC. Quantitation of selective autophagic protein aggregate degradation invitro and in vivo using luciferase reporters. Autophagy 2009;5:511-9
39. Medina R, Wing SS, Haas A, Goldberg AL. Activation of the ubiquitin- ATP-dependent proteolytic system in skeletal muscle during fasting and denervation atrophy. Biomed Biochim Acta 1991;50:347-56
40. Wing SS, Goldberg AL. Glucocorticoids activate the ATP-ubiquitindependent proteolytic system in skeletal muscle during fasting. Am J Physiol 1993;264:E668-76
41. Ferguson WW, Fidler MR, Folkmann CK, Starling Jr. Correlation of lysosomal enzymes and cachexia in the tumor-bearing rat. J Surg Res1979;26:150-6
42. Deans DA, Tan BH, Wigmore SJ, Ross JA, de Beaux AC, Paterson- Brown S, Fearon KC. The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer. Br J Cancer 2009;100:63-9
43. Briet F, Twomey C, Jeejeebhoy KN. Relationship between metabolism and peripheral blood mononuclear cell mitochondrial complex I activity before and after a short-term refeeding in weight-losing cancerpatients. Clin Nutr 2003;22:247-53
44. Schaap LA, Pluijm SM, Deeg DJ, Harris TB, Kritchevsky SB, Newman AB, Colbert LH, Pahor M, Rubin SM, Tylavsky FA, et al. Higher inflammatory marker levels in older persons: associations with 5-yearchange in muscle mass and muscle strength. J Gerontol A Biol Sci MedSci 2009;64:1183-9
45. Fouladiun M, Korner U, Bosaeus I, Daneryd P, Hyltander A, Lundholm KG. Body composition and time course changes in regional distributionof fat and lean tissue in unselected cancer patients on palliativecare-correlations with food intake, etabolism, exercise capacity, and hormones. Cancer 2005;103:2189-98